Topic: venture capital (VC)
The appointment means Gentile will commit full time to the autophagy startup he helped get off the ground.
Robotic surgery platform developer Auris Health has raked in another $220 million in equity financing, bringing its total to more than $700 million.
The series D positions ViaCyte to generate phase 1/2 data on one candidate while working to get another back into the clinic.
Rheostat Therapeutics raised $23 million to develop treatments for neurodegenerative and rare diseases by targeting the cell’s garbage disposal.
Illumina Ventures led a €16 million round for Stilla Technologies, a Paris-based developer of digital PCR solutions for genetic analysis.
The Forbion-led series B tees up Inflazome to trial its NLRP3 inflammasome inhibitors in several inflammatory diseases.
Neurodegenerative disease startup QurAlis has extended the seed round it first announced in April, bringing its total funding up to $5.5 million.
Silicon Valley Bank parent SVB is buying Leerink to create a new company with a "complete capital markets offering."
Deerfield Management committed up to $80 million to fund a new center at the Dana-Farber Cancer Institute set on exploring protein degradation.
The financing, which comes 15 months after Roivant raised $1.1 billion, is tied to a $7 billion valuation for the fast-growing biotech.